Skip to main content
. 2009 Sep 28;15(36):4511–4517. doi: 10.3748/wjg.15.4511

Figure 1.

Figure 1

Immunohistochemistry of biliary tract cancer specimens for expression of HER2 (A, C, E and G) and EGFR (B, D, F and H). A: HER2 neg.; B: EGFR neg.; C: HER2 1+; D: EGFR 1+; E: HER2 2+; F: EGFR 2+; G: HER2 3+; H: EGFR 3+.

HHS Vulnerability Disclosure